Search for: All records

As pharmaceutical manufacturing is transitioning from traditional batch to continuous manufacturing (CM), there is a lack of tools for CM design and development, which can integrate drug substance and drug product unit operations for overall evaluation. Recently, a Python-based PharmaPy framework was proposed to advance the design, simulation, and analysis of continuous pharmaceutical processes. However, the initial library of models only addressed upstream drug substance processing. In this work, new capabilities, including drug product unit operations such as feeder, blender, and tablet press, have been added to the PharmaPy framework, enabling end-to-end study and optimizing the effects of material properties and process conditions on solid oral dosage products. The platform supports computational efficiency and model accuracy by allowing the development of different mechanistic and semi-mechanistic models. Sensitivity analysis is performed on the integrated end-to-end simulator to identify critical input variables influencing product quality and control strategies. The analysis lowers the complexity of the model by ranking significant input variables. Finally, feasibility studies are conducted on extracted influential input variables to characterize the process design space and achieve desirable output. The enhanced PharmaPy package can now support decision-making from early research and development stages through manufacturing. 

Continuous manufacturing in pharmaceutical industries has shown great promise to achieve process intensification. To better understand and justify such changes to the current status quo, a technoeconomic analysis of a continuous production must be conducted to serve as a predictive decision-making tool for manufacturers. This paper uses PharmaPy, a custom-made Python-based library developed for pharmaceutical flowsheet analysis, to simulate an annual production cycle for a given active pharmaceutical ingredient (API) of varying production volumes for a batch crystallization system and a continuous mixed suspension, mixed product removal (MSMPR) crystallizer. After each system is optimized, the generalized cost drivers, categorized as capital expenses (CAPEX) or operational expenses (OPEX), are compared. Then, a technoeconomic and sustainability cost analysis is done with the process mass intensity (PMI) as a green metric. The results indicate that while the batch system does have an overall lower cost and better PMI metric at smaller manufacturing scales in comparison with the continuous system, the latter system showed more potential for scaling-up for larger production volumes. 

The determination of the design space (DS) in a pharmaceutical process is a crucial aspect of the quality-by-design (QbD) initiative which promotes quality built into the desired product. This is achieved through a deep understanding of how the critical quality attributes (CQAs) and process parameters (CPPs) interact that have been demonstrated to provide quality assurance. For computational inexpensive models, the original process model can be directly deployed to identify the design space. One such crucial process is the Tablet Press (TP), which directly compresses the powder blend into individual units of the final product or adds dry or wet granulation to meet specific formulation needs. In this work, we identify the design space of input variables in a TP such that there is a (probabilistic) guarantee that the tablets meet the quality constraints under a set of operating conditions. A reduced-order model of TP is assigned for this purpose where the effects of lubricants and glidants are used to characterize the design space to achieve the desired tablet CQAs. The probabilistic design space, which takes into account interactions between crucial process parameters and important quality characteristics including model uncertainty, is also approximated because of the high cost associated with the comprehensive experiments. 

We present a systematic and automatic approach for integrating tableting reduced-order models with upstream unit operations. The approach not only identifies the upstream critical material attributes and process parameters that describe the coupling to the first order and, possibly, the second order, but it also selects the mathematical form of such coupling and estimates its parameters. Specifically, we propose that the coupling can be generally described by normalized bivariate rational functions. We demonstrate this approach for dry granulation, a unit operation commonly used to enhance the flowability of pharmaceutical powders by increasing granule size distribution, which, inevitably, negatively impacts tabletability by reducing the particle porosity and imparting plastic work. Granules of different densities and size distributions are made with a 10% w/w acetaminophen and 90% w/w microcrystalline cellulose formulation, and tablets with a wide range of relative densities are fabricated. This approach is based on product and process understanding, and, in turn, it is not only essential to enabling the end-to-end integration, control, and optimization of dry granulation and tableting processes, but it also offers insight into the granule properties that have a dominant effect on each of the four stages of powder compaction, namely die filling, compaction, unloading, and ejection. 

Implementing a condition-based maintenance strategy requires an effective condition monitoring (CM) system that can be complicated to develop and even harder to maintain. In this paper, we review the main complexities of developing condition monitoring systems and introduce a four-stage framework that can address some of these difficulties. The framework achieves this by first using process knowledge to create a representation of the process condition. This representation can be broken down into simpler modules, allowing existing monitoring systems to be mapped to their corresponding module. Data-driven models such as machine learning models could then be used to train the modules that do not have existing CM systems. Even though data-driven models tend to not perform well with limited data, which is commonly the case in the early stages of pharmaceutical process development, application of this framework to a pharmaceutical roller compaction unit shows that the machine learning models trained on the simpler modules can make accurate predictions with novel fault detection capabilities. This is attributed to the incorporation of process knowledge to distill the process signals to the most important ones vis-à-vis the faults under consideration. Furthermore, the framework allows the holistic integration of these modular CM systems, which further extend their individual capabilities by maintaining process visibility during sensor maintenance.